Advertised as the “sour candy that doesn’t suck,” Sour Strips gained a following on social media since its 2019 introduction.

AppLovin might be the next breakout in retail media. Plus, some advertiseres have already turned off TikTok Smart+.

The advertisements from Polymarket have been controversial, with some of them not being clearly marked as reflecting odds that are based on bets.

Gaming advertising platform Anzu and kidtech company SuperAwesome recently released a new report on which they collaborated. The report, called “Gaming the future: how to make an impact with younger ...

"We are pleased to announce positive head-to-head clinical data for our non-adjuvanted SCB-1019 RSV vaccine candidate compared to AS01E-adjuvanted AREXVY, indicating our potential best-in-class ...

WHAT TO WATCH --VACCINES: Investors' concerns linger over sales expectations for the company's respiratory syncytial virus vaccine Arexvy and its best-selling shingles vaccine Shingrix for the ...

A screenshot from a Donald Trump ad taking issue with Kamala Harris over Social Security. WLRN has partnered with PolitiFact to fact-check Florida politicians. The Pulitzer Prize-winning team ...

Search Engine Land » PPC » Amazon non-endemic ads: Winning strategies for service ... delivering measurable results within paid search, paid social media and programmatic campaigns.

A two-minute ad aired by the Trump campaign during Sunday’s NFL Philadelphia Eagles game, depicting the United States “gone to hell” under the Biden administration, is being mocked for using ...

“President Trump will cut taxes again. No taxes on tips, overtime or Social Security,” the ad says. The campaign spent about $2.3 million airing in North Carolina, about $2 million in ...

GSK's major growth drivers, Shingrix and Arexvy, along with recent legal progress, make its current undervaluation unjustified, leading to a "Strong Buy" rating. The company’s diversified ...

GSK plc announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at increased risk for RSV-LRTD due to certain underlying medical ...